These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 39231777)

  • 1. [Daratumumab for the treatment of relapsed T-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a case report].
    Wang X; Hu MM; Xiao JY; Lin ZH; Shi TT; Li XF; Qiu HY
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jul; 45(7):698. PubMed ID: 39231777
    [No Abstract]   [Full Text] [Related]  

  • 2. Case report: CD7-targeted autologous CAR-T therapy for the treatment of T-cell acute lymphoblastic leukemia undergoing allogeneic peripheral blood stem cell transplantation in the long-term follow-up.
    Li LL; Xia YP; Li Q; Wang P; Sun PP; Wang XG; Zhang R
    Front Immunol; 2024; 15():1469251. PubMed ID: 39620223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term exposure and response to azacitidine for post-hematopoietic stem cell transplantation relapse of early T-cell precursor acute lymphoblastic leukemia: a case report and review of the literature.
    Jeanselme P; Tavitian S; Lapierre L; Vergez F; Rigolot L; Huynh A; Bertoli S; Delabesse E; Huguet F
    Leuk Lymphoma; 2024 Dec; 65(13):2025-2030. PubMed ID: 39141583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two novel assays demonstrate persistent daratumumab exposure in a pediatric patient with delayed engraftment following allogeneic hematopoietic stem cell transplantation.
    Major-Monfried H; Hosszu K; McAvoy DP; Vallone A; Shukla N; Gillio A; Spitzer B; Kung AL; Cancio M; Curran K; Scaradavou A; Oved JH; O'Reilly RJ; Boelens JJ; Harris AC
    Cytotherapy; 2024 May; 26(5):466-471. PubMed ID: 38430078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS study.
    Bhatla T; Hogan LE; Teachey DT; Bautista F; Moppett J; Velasco Puyó P; Micalizzi C; Rossig C; Shukla N; Gilad G; Locatelli F; Baruchel A; Zwaan CM; Bezler NS; Rubio-San-Simón A; Taussig DC; Raetz EA; Mao ZJ; Wood BL; Alvarez Arias D; Krevvata M; Nnane I; Bandyopadhyay N; Lopez Solano L; Dennis RM; Carson R; Vora A
    Blood; 2024 Nov; 144(21):2237-2247. PubMed ID: 39158071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of allogeneic hematopoietic stem cell transplantation based on a total body irradiation conditioning treatment regimen for adult acute lymphocytic leukemia].
    Xiao QQ; Yu XL; Song XC; Hou YX; Deng L; Li WJ; Zhou F
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):249-256. PubMed ID: 38716596
    [No Abstract]   [Full Text] [Related]  

  • 7. [Analysis of the therapeutic effect of avatinib bridged allogeneic hematopoietic stem cell transplantation on 7 cases of recurrent/refractory RUNX1-RUNX1T1 positive acute myeloid leukemia with KIT mutations].
    Han SY; Zhou HX; Han Y; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2024 Aug; 45(8):767-771. PubMed ID: 39307724
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical efficacy of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome-evolved acute myeloid leukemia].
    Chen SL; Shi YY; Zhang LN; Gong M; Zhang XY; Zhao XL; Hao MZ; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
    Zhonghua Xue Ye Xue Za Zhi; 2024 Apr; 45(4):364-369. PubMed ID: 38951064
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of Ruxolitinib with corticosteroids in idiopathic pneumonia syndrome post-allogeneic hematopoietic stem cell transplantation: A single-center experience and systematic review.
    Shahzad M; Khan MA; Amin MK; Sarfraz Z; Zulfiqar F; Qasim H; Bansal R; Brownback K; Ahmed N; Abhyankar SH; McGuirk JP; Singh AK; Mushtaq MU
    Transpl Immunol; 2024 Dec; 87():102135. PubMed ID: 39368752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and safety of venetoclax combined with decitabine, modified HA regimen and DLI in the treatment of relapsed pediatric AML/MDS after allogeneic hematopoietic stem cell transplantation].
    Zhang F; Wang HF; Hu GH; Suo P; Bai L; Wang Y; Zhang XH; Huang XJ; Cheng YF
    Zhonghua Xue Ye Xue Za Zhi; 2024 Sep; 45(9):832-837. PubMed ID: 39414606
    [No Abstract]   [Full Text] [Related]  

  • 11. Chidamide maintenance therapy after allo-HSCT in SET-NUP214 fusion positive T-ALL patients: A report of two cases.
    Song J; Liu J; Guo D; Li H; Fan S
    Transpl Immunol; 2024 Dec; 87():102119. PubMed ID: 39233093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group.
    Xu LP; Lu PH; Wu DP; Huang H; Jiang EL; Liu DH; Cao WJ; Zhang X; Fu YW; Li NN; Chen XC; Zhu XY; Liu QF; Xia LH; Zhang YC; Xu YJ; Li FC; Hu J; Liu SX; Liu RR; Ma XD; Tang XW; Luo Y; Zhang XH; Huang XJ;
    Bone Marrow Transplant; 2024 Dec; 59(12):1726-1734. PubMed ID: 39322652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress of allogeneic hematopoietic stem cell transplantation in KMT2A-rearranged acute leukemia].
    Liu J; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2024 May; 45(5):514-520. PubMed ID: 38964931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase II, Open-Label Study of Lenalidomide and Dexamethasone Followed by Donor Lymphocyte Infusions in Relapsed Multiple Myeloma Following Upfront Allogeneic Stem Cell Transplant.
    LeBlanc R; Thiant S; Terra R; Ahmad I; Claveau JS; Bambace N; Bernard L; Cohen S; Delisle JS; Lachance S; Kiss T; Roy DC; Sauvageau G; Roy J
    Curr Oncol; 2024 Nov; 31(11):7258-7274. PubMed ID: 39590165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a report of three cases and literature review].
    Feng AH; Shi JM; Fu HR; Yu J; Zheng WY; Zhu YY; Huang H; Zhao YM
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jul; 45(7):689-693. PubMed ID: 39231775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of therapeutic effects of allogeneic hematopoietic stem cell transplantation in 12 patients with DEK-NUP214 fusion gene positive acute myeloid leukemia].
    Shen YY; Yang DL; He Y; Pang AM; Chen X; Ma QL; Zhang RL; Wei JL; Zhai WH; Han MZ; Jiang EL; Feng SZ
    Zhonghua Xue Ye Xue Za Zhi; 2024 Apr; 45(4):383-387. PubMed ID: 38951067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory and clinical effects of daratumumab in T-cell acute lymphoblastic leukaemia.
    Cerrano M; Castella B; Lia G; Olivi M; Faraci DG; Butera S; Martella F; Scaldaferri M; Cattel F; Boccadoro M; Massaia M; Ferrero D; Bruno B; Giaccone L
    Br J Haematol; 2020 Oct; 191(1):e28-e32. PubMed ID: 32686081
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperbaric oxygen therapy in the treatment of late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.
    Arana Ribeiro J; Alpuim Costa D; Gaio-Lima C; Guilherme Gonçalves-Nobre J; Portugal Rodrigues I; Trigo Miranda M; Pinho Vaz C; D'Espiney Amaro C; Camacho Ó
    Sci Rep; 2024 Oct; 14(1):24658. PubMed ID: 39428542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. InsT-ALLing CD7 chimeric antigen receptors before transplantation.
    Delgado J
    Br J Haematol; 2024 Jun; 204(6):2155-2156. PubMed ID: 38676290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia.
    Nath K; Lee J; Elko TA; Levy L; Preston E; Devlin SM; Ponce DM; Lin RJ; Shaffer BC; Cho C; Politikos I; Jakubowski AA; Park JH; Rampal R; Perales MA; Tallman MS; Barker JN; Berman E; Tamari R; Stein E; Giralt SA; Gyurkocza B
    Am J Hematol; 2023 Dec; 98(12):1869-1876. PubMed ID: 37688521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.